Silent pulmonary embolism in patients with a permanent transvenous pacemaker  by Ito, Tatsuo et al.
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All Cases (n = 60) Male Cases (n = 37) Female Cases (n = 23) 
HHE 51% 40% 60% 
Odds Ratio 9.8* 2.9* 8.2" 
(g0% C;I.) (4.3-24) (1.1--8.2) (2.2-30.7) 
• p < 0.01 cumpamd with conl~ols. 
Conclu,~ions: High ptasm~ homocysteine concentration is a poweffu( risk 
factor for thrombosis in both man and women. Since homocysteine can be 
reduced by B vitamins, a possible therapeutic role for these agents may 
exists in patients with thromboerobolism. 
~ Aceelerated Thrombolysls  Using a New 
Intravascular  Therapeutic Ultrasound Catheter 
Katsuro Tachibena, Shunro Tachibens. Fukuoka University and Wakasugi 
Medical Research Institute, Fukuoka, Japan 
Preclinical expedments were carded out to evaluate the perfOrmance and 
safety of a newly developed catheter, tipped with a ultrasound transducer 
designed to accelerate thrombolysis. Urokinese (UK, 24OIU/rot) was added 
to arliticlal thrembus produced by in vifre Chandler's tubes (diameter 3 taro). 
The roiniature ultrasound (US) emiiting ceramic element (diameter 1 ram) 
mounted at the tip of a 3F catheter was inserted directly inside the tube near 
the artificial throrobus. US (1 MHz) was exposed for a total of 60 sec at an 
intensity of 0.3 W/crib. Fibrinolysis was determined by the percentage of 
weight loss of throrobus after incubation of 15 to 90 minutes. 
Incubation (mini 
15 30 60 go 
UK alone 12 ± 2.4 28 ± 2.6 40 4-1.2 46 :t: 4.6 
UK+US 33±6,1" 44:t:3.3' 56±7.2* 67±1.8" 
n = 5, *Significant difremnses, UK vs UK + US, p < 0.05 
US exposure atone showed no fibrinolysis. 
Ultrasound exposed for durations of 30 minutes with tne same device and 
conditions to normal rabbit (n = 5) abdominal aorla resulted in no significant 
tissue damage (Histological and SEM observations). 
Conclusion: Therapeutic ultrasound emission from the new flexible in- 
travescular catheter accelerated thrombelysis. Clinical application of this 
device for peripheral vascular thrombosis is anticipated. 
~ 7  Silent Pulmonary Embolism in Patients With a 
Permanent lYansvenous Pacemaker 
Tatsuo liD, Jun Tanouchl, MIwa Kitamura, Jun]i Kato, Toshikazu Modoka, 
Mesaroi Nishino, Kunimitsu Iwai, Hldeo Tanabeshi, Yoshio Yameda. Osaka 
Rosai Hospital, Osaka, Japan 
Pulmonary embolism (PE) is a frequently silent but occasionally sedous 
complication of permanent rensvenous p~_cing. To examine the correlation 
between PE and venous route thrombus, age, sex, follow-up interval, type of 
pacaroaker (DDD or VVI), cardiac function and type of arrhythrota in patients 
(pts) with permanent ransvenous pacing, we performed pulmonary perfu- 
sion sclntlgraphy (PPS), digital subtraction angiogrephy (DSA) and trans- 
esophageal echocardiography (TEE) in 42 pts with a pacemaker who did not 
take anticoegulation therapy. The pts ware divided into two groups according 
to the presence of perfuston defect by PPS; 29 pts without paffuslon defect 
(PE-) and 13 pts with parfuslon defect (PE+). Of 36 pts, 15 pts (35,7%) 
coropllcated venous throrobus by DSA and 2 pts (4.8%) complicated right 
atrial thrombus by TEE. 
PE(+) . PSi-) p 
Age 704-12 66 4- 10 n.s. 
Sex (% male) 46.2 51.7 n.s. 
Follow.up Intsrval (ym) 5.3 ± 4.5 5.0 4- 3.2 n.s. 
of pacemaker (% DDD) 38.5 24.1 n.s. 
Ejection fraction (%) 64 ± 12 70 ± 6 n.s. 
Atdal fibrillation (%) 30.8 6.9 <0.05 
Venous route thtembus (%1 78.9 17.2 <0.001 
We conclude atdal fibdllatlon and venous thrombus frequently bring about 
PE in pts with a transvenous pacemaker and suggesting that origin of threm- 
bus causing PE is mainly venous thrombus of upper limb. 
Risk Factors Altering 
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~ Circadian Variation of Ventrlcular 
Tachyarrhythmlas In Patients With and Without 
Coronary Artery Disease 
Stetfen Behrens0 Christoph Ehlero, Thomas Br0ggeroasn, Wolfgang Ziss, 
Felix Lampe, Dieldch Andresen, Hans-Peter Schutthetss. Free University, 
Berlin, Germany 
Myocardial ischemia has been proposed to be a major mechanism for the 
morning peak of acute myocardial infarction and malignant arthythmlas re- 
sulting in sudden cardiac death. However, little is known about the circadian 
variation of arrhythmies in patients without ischemtc heart disease. The pur- 
pose of this study was to compare the diurnal distribution of life-threatenieg 
venfficular tashyan'hythroias in patients with and without coronary artery 
disease (CAD). 
We studied 159 patients with an implantabte defibrillator (ICO). During 
fol10w-up 87 patients (55%) had spontaneous appropriate shock episodes 
(SE). The underlying heart disease was CAD in 53 patients (61%). Thirtyfour 
patients (39%) had nonlschemic heart disease (dilated cardiomyopathy n 
= 22, arrhythroogenic right ventricle n --- 3, valve replacement n = 4, no 
structural heart disease n = 5)..time distribution (TD) of SE (calculated as 
percentage of SE at 0-6/6-12/12-18/18-24 hours) was determined in all 
patients and in those with and without ischemic heart disease, SE (n = 448; 
mean 5.3 44 7.3) in all patients showed a clear circadian variation (TD of SE 
(%): 18/35/27/20, p < 0.001) with a morning peak. In patients with CAD the 
same dis~bution of SE (n = 289) was observed (TD of SE (%): 14140127/19, 
p < 0.001). However, in patients without ischemic beart disease SE (n = 
159) were evenly dis|dbuted (TD of SE (%): 23/28/27/22, p = 0.8S). If directly 
compared SE were distributed significantly different between both subgroups 
(p = 0.02). 
Patients with CAD exhibit a circadian variation of SE. In contrast, those 
patients without ischemic heart disease demonstrate an even distribution 
of SE. These findings may underline the role of ischemia for the genesis 
of malignant arrhythmlas in ICD patients and may help to develop specific 
therapeutical strategies in this patient population. 
~-~-~ Beneficial Effects of Cardiac Rehabilitation and 
Exercise Training on Autonomic Determinants of 
Risk 
Daniela Lucini 1 Richard V. Milani2 Massimo Pagard 1, Alberto Maltiani 1, 
Cad J. Lavie 2, Joseph P. Murgo =. 1 CNR, Ospedale "L. Sacco ~, Universita 
di Milano, Italy; 20chsner Medical Institutions, New Orleans, LA 
Autonomic nervous system variables including beroreflex and heart rate 
variability have been shown to predict prognosis following major cardiac 
events. Although cardiac rehabilitation and exercise training (CR) reduce 
subsequent major CHD events, the effects of this therapy with standard 
regimens on autonomic variables are not known. Accordingly, we studied 20 
consecutive patients following a major CHD event, beth before and after a 
formal 12-week outpatient, phase II CR program, to determine the effects of 
this therapy on autonomic variables, and compared these results to 8 similar 
CHD patients who did not padictpate in formal CR. A standard medlcat 
regimen for CHD was used in all patients and was not altered during the 
program. Analysis of RR interval and systelic arterial pressure provided a 
measure of heart rate variability (RR interval variance, a 2) and of bororetiex 
gain [by the frequency domain index {cr)]. Results are: 
SAP RR o 2 a 
(mmHg) {mast) (msec 2) {mseP-JmmHg) 
Rahab Entry 1274-16 966 ~: 102 538 :t: 394 6.6:1:0,9 
patients Exit 1234-16 10764-204* 12024-835* 10.44-4.4" 
Control Entry 124:t:10 9614-95 604 d:487 6.64-2.1 
patients Exit 1254- 29 1039 4-105  850 ~ 565 8.8 -I- 8.0 
Data ate expressed as median :1: Semi Inter Quartile. *p < 0.05 EntTy vs Exit (non- 
parametric ANOVA) 
Conclusion:CR resulted in significant improvements in autonomic function, 
including signilicact increases in RR interva/, of its vadecca, and of baroreflex 
gain. These improvements may influence the overall benefits of CR programs 
in the secondary prevention of CHD above and beyond those provided by 
standard medical regimens. 
